Highlights Nutra Pharma Corp.

Equities

NPHC

US67060U2087

Delayed OTC Markets Other stock markets 09:33:05 2024-06-24 am EDT			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	+9,900.00%

Mar. 22	Nutra Pharma Corporation Appoints Michael Flax as CFO	CI
Mar. 22	Nutra Pharma Corporation Announces Management Changes	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Nutra Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Nutra Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-22	CI
Nutra Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-20	CI
Nutra Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-15	CI
Nutra Pharma Announces First Manufacturing Agreement	22-03-23	CI
Nutra Pharma Expands Manufacturing Capabilities	22-03-17	CI
Nutra Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Nutra Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	21-07-01	CI
Nutra Pharma Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	21-05-07	CI
Nutra Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	21-02-05	CI
Nutra Pharma Announces Availability of Nyloxin on the iRemedy Marketplace	19-05-30	CI
Nutra Pharma and JAH Neal Holdings LLC Sign Definitive Letter of Intent for $4 Million Joint Venture Financing	18-06-28	CI
Nutra Pharma Corporation Partners with NxGen Brands, LLC for Nyloxin Distribution	18-04-19	CI
Nutra Pharma Corporation Files Provisional Patent for the Treatment of Amyotrophic Lateral Sclerosis	18-04-10	CI
Nutra Pharma Corporation Signs Definitive Distribution Agreement with Pharmachal PTY LTD	18-02-01	CI
Nutra Pharma Corporation Partners with EuroAmerican IP, LLC to Distribute Nyloxin for Sale to Government Agencies	18-01-18	CI
Nutra Pharma Corp. Launches Luxury Feet	17-06-21	CI
Nutra Pharma Corporation Announces Collaboration with International Security Group to Develop Nerve Agent Counter Measures	17-05-23	CI
Nutra Pharma Corporation Announces Licensing and Marketing Agreement for Pet Pain-Away	16-11-09	CI
Nutra Pharma Corporation Announces Manufacturing Alliance with Omnia Biologics to Produce RPI-78M for Clinical Trials in Pediatric Multiple Sclerosis	16-09-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nutra Pharma Corp.

Equities

NPHC

US67060U2087

Highlights

Filters